Is Belzutifan available for purchase in India? Patient purchasing channels and pricing information

Belzutifan (Belzutifan) is a targeted drug used to treat specific tumors. It has been officially launched in China, but it has not yet been included in the medical insurance system, which means that patients need to bear higher drug costs when purchasing domestically. Regarding the situation in the Indian market, there is currently no Indian version of the generic version of besetivan, which prevents patients from obtaining the drug at a lower price through Indian channels.

Since there is no generic version of bezutivan in the Indian market, if patients want to purchase it through overseas channels, they can mainly consider the generic version in Laos. The price of the Laotian version of besetifan is relatively affordable, about more than 5,000 yuan, and the ingredients of this version are basically the same as the original drug, ensuring the effectiveness and safety of the treatment.

For domestic patients, although the drug is already on the market, it is not included in medical insurance, making the treatment cost higher. Patients need to pay special attention to the specific price information of the hospital pharmacy when purchasing. It is recommended that patients communicate with their attending doctor in detail before using bestivan to understand the drug's efficacy, cost and possible payment options, and plan a reasonable treatment budget.

In general, India currently does not provide generic drugs of besotivan. If patients need to purchase the drug, in addition to purchasing it in regular domestic hospital pharmacies, they can also consider obtaining generic drugs through overseas channels such as Laos. When purchasing, be sure to ensure the formality and quality of the medicine to ensure the therapeutic effect and medication safety.

Reference materials:https://www.welireg.com/